Natural Alternatives International Inc.
Organization details
- Legal name
- Natural Alternatives International Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2833 — Medicinal Chemicals & Botanical Products
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Carlsbad
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- NAII
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000787253
- EIN
- 84-1007839
- Wikidata ID
- Q15109912
Board of directors
-
Alan G. Dunn · DirectorSince 2023
-
Guru Ramanathan · DirectorSince 2023
-
Laura Kay Matherly · DirectorSince 2023
-
Mark A. Ledoux · Director · CEO/ChairmanSince 2023
Chief executives
Director election results
Annual meeting of December 5, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $26,844
- 14 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | WOLF KENNETH Officer (President, COO, & Sec.) | Shares withheld for tax | −5,151 | $2.73 | $14,062 |
| Mar 6, 2026 | Fortin Michael E Officer (Chief Financial Officer) | Shares withheld for tax | −4,308 | $2.73 | $11,761 |
| Mar 6, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Shares withheld for tax | −3,484 | $2.73 | $9,511 |
| Mar 6, 2026 | Alan G. Dunn Director | Grant or award | +8,000 | — | — |
| Mar 6, 2026 | Laura Kay Matherly Director | Grant or award | +8,000 | — | — |
| Mar 6, 2026 | Guru Ramanathan Director | Grant or award | +8,000 | — | — |
| Mar 6, 2026 | WOLF KENNETH Officer (President, COO, & Sec.) | Grant or award | +15,000 | — | — |
| Mar 6, 2026 | Fortin Michael E Officer (Chief Financial Officer) | Grant or award | +12,000 | — | — |
| Mar 6, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Grant or award | +20,000 | — | — |
| Mar 6, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Open-market purchase | +532 | $2.80 | $1,490 |
| Mar 5, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Open-market purchase | +218 | $2.75 | $600 |
| Mar 4, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Open-market purchase | +500 | $2.77 | $1,385 |
| Mar 2, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Open-market purchase | +500 | $2.79 | $1,395 |
| Feb 27, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Open-market purchase | +500 | $2.85 | $1,425 |
| Feb 27, 2026 | Mark A. Ledoux Director, Officer (CEO/Chairman), 10% owner | Open-market purchase | +250 | $2.80 | $700 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Natural Alternatives International Inc.
Who is the CEO of Natural Alternatives International Inc.?
Mark A. Ledoux is Natural Alternatives International Inc.'s CEO/Chairman.
How many directors are on Natural Alternatives International Inc.'s board?
Natural Alternatives International Inc.'s board has 4 directors: Alan G. Dunn, Guru Ramanathan, Laura Kay Matherly and Mark A. Ledoux.
Are Natural Alternatives International Inc. insiders buying or selling shares?
Over the last 12 months, Natural Alternatives International Inc. insiders bought $26,844 of shares in 14 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="natural-alternatives-international-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.